Millie Summary: AI is reshaping the economics of pharmaceutical R&D by improving scientific decision-making, helping researchers evaluate more possibilities, eliminate weaker candidates earlier, and concentrate expensive laboratory and clinical resources on the opportunities supported by the strongest evidence. For medical-aesthetics manufacturers, the larger opportunity is increasing scientific throughput across the entire product lifecycle, from discovery...Read More